tiprankstipranks
Galmed Pharmaceuticals (GLMD)
NASDAQ:GLMD

Galmed Pharmaceuticals (GLMD) Cash flow

1,144 Followers

Galmed Pharmaceuticals Cash Flow

GLMD's free cash flow for Q4 2022 was $―. For the 2022 fiscal year, GLMD's free cash flow was decreased by $14.40M and operating cash flow was $―. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -14.48M$ -18.50M$ -32.89M$ -26.29M$ -14.94M$ -9.02M
Investing Cash Flow
$ 15.58M$ 17.56M$ 11.46M$ 16.54M$ 6.68M$ -60.02M
Financing Cash Flow
$ 70.00K$ 70.00K$ 17.37M$ 768.00K$ 143.00K$ 80.18M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 10.12M$ 2.13M$ 3.00M$ 7.06M$ 16.04M$ 24.16M
Income Tax Paid Supplemental Data
---$ 0.00$ 0.00$ 75.00K
Interest Paid Supplemental Data
-$ 297.00K$ 562.00K$ 1.19M$ 1.95M$ 865.00K
Issuance Of Capital Stock
$ 70.00K$ 70.00K$ 17.37M$ 707.00K$ 0.00$ 79.15M
Issuance Of Debt
------
Repayment Of Debt
------
Free Cash Flow
$ -14.48M$ -18.50M$ -32.90M$ -26.33M$ -14.95M$ -9.11M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Galmed Pharmaceuticals Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis